Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that the Company will host an investor meeting and webcast to discuss interim results from the GALAXY-1 trial, a randomized Phase 2b/3 study designed to evaluate ganetespib in combination with docetaxel for the treatment of advanced non-small cell lung cancer at the 2013 American Society of Clinical Oncology (ASCO) Annual Meeting, which is taking place May 31 – June 4 in Chicago.
Help employers find you! Check out all the jobs and post your resume.
